CARPL.ai is a radiology AI platform founded by Dr. Vidur Mahajan, operational since 2021, positioning itself as the largest marketplace of its kind with 275+ applications from 100+ AI vendors. The company raised a $6 million seed round led by Stellaris Venture Partners, with participation from investors connected to Novo Holdings, Bain & Co, and UnitedHealth Group.
Rather than building its own diagnostic AI, CARPL lets hospitals and imaging centers test third-party radiology algorithms against their own patient data inside their own infrastructure before deploying any of them clinically, then run the chosen algorithms inside a universal AI viewer that standardizes how results from different vendors get displayed and annotated. That vendor-neutral structure is the platform's core differentiator against single-vendor radiology AI tools.
CARPL is built for hospital radiology departments and imaging networks evaluating multiple AI vendors rather than a solo radiologist shopping for one tool, it is FDA-cleared as a marketplace platform. Pricing is not published; the company sells enterprise access with custom quotes based on deployment scale.
